News
Taking Aspirin Does Not Decrease Risk of Vision Loss in Elderly
Aspirin is a cheap over-the-counter-medication that is often hailed for its benefits in reducing the risk of heart attack in patients. However, aspirin does not? decrease the risk of vision loss in...
Patient's Own Stem Cells May Provide Treatment for AMD
Stem cells that can be derived from patients may? provide a possible treatment for age-related macular degeneration (AMD). Unlike embryonic stem cells which can cause an immune rejection in the pat...
Study Finds No Link Between Statins and Risk of Advanced AMD
There is good news for people who take statins to reduce their cholesterol levels. A study published in the December 2009 issue of Ophthalmology concludes that the use of statins
These Great Letters Keep Us Going!
Each week or two, I get several email responses to my Sight For Life newsletter. (If you're not already getting this, you can sign up for free at by clicking HERE).
I personally respond to each ...
The Symptoms and Causes of Peripheral Vision Loss
Peripheral vision affects many areas of our lives, including driving. It is also an integral part of team sports such as football and basketball. Unlike other visual problems, peripheral vision los...
Strong Link Found Between Visual Symptoms and Quality of Life
The eyes can be a good indicator of a person's overall physical and mental health. Visual symptoms can aid a physician in correctly diagnosing other physical and mental problems.
Best Test for Measuring Diabetes Control
In the twenty years that I've been in practice, I've witnessed a skyrocketing rate of Diabetes Mellitus. More than half of the diabetics in my practice are poorly controlled, and each week it seems...
Computer Vision Syndrome Poses Risk to Students' Vision
Children today are growing up as a computer generation. Along with the benefits of being computer savvy, there are risks of too much time in front of a monitor. Computer Vision Syndrome (CVS) is ca...
New Treatment for Wet Age-Related Macular Degeneration in FDA Clinical Trials
The NeoVista Vidion ANV Therapy System is currently undergoing phase 3 clinical trials for FDA approval. The Vidion system is used to treat wet age-related macular degeneration (AMD). It is an epim...